Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05967169 · ClinicalTrials.gov registry record · NA
EFS of Bioabsorbable Implant for NSD
A NA study of Nasal Septal Deviation, sponsored by Spirair.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT05967169 is a NA study of Nasal Septal Deviation that is active but no longer recruiting, run by Spirair. The registered enrollment target is 30 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT05967169, a NA study of Nasal Septal Deviation, is active but no longer recruiting, sponsored by Spirair.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
Early feasibility study of bioabsorbable implant and delivery device for correction of septal deviation
Conditions Studied
Interventions
- DEVICE Nasal Septal Strap implantation
Study Locations (2)
California
- Breathe Clear Institute - Torrance
Pennsylvania
- Specialty Physicians - Bethlehem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-05-25 |
| Est. Completion | 2025-12-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05967169
The ClinicalTrials.gov registry entry for NCT05967169 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spirair, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nasal Septal Deviation appearing as the primary indexed condition, and to 1 intervention - of which Nasal Septal Strap implantation is the first listed.
NCT05967169 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05967169 about?
NCT05967169 is a clinical study titled "EFS of Bioabsorbable Implant for NSD". Early feasibility study of bioabsorbable implant and delivery device for correction of septal deviation
What is the current status of trial NCT05967169?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-05-25. Estimated completion is 2025-12-08.
What conditions does trial NCT05967169 study?
This clinical trial studies the following conditions: Nasal Septal Deviation.
What interventions are being tested in trial NCT05967169?
The interventions under investigation include: Nasal Septal Strap implantation (DEVICE).
Who is sponsoring clinical trial NCT05967169?
This trial is sponsored by Spirair, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05967169 being conducted?
This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nasal Septal Deviation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.